Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipid peroxidation pathway is a series of chemical reactions in which oxidants attack lipids, especially polyunsaturated fatty acids (PUFAs), leading to their oxidative degradation. It is a major form of oxidative damage in biological systems and is implicated in various diseases, including atherosclerosis, neurodegeneration, and cancer. The pathway involves initiation, propagation, and termination phases, with key products like MDA, 4-HNE, and isoprostanes serving as biomarkers. Regulation involves enzymatic and non-enzymatic antioxidant defenses. While not a single druggable target, modulating the pathway via antioxidants or specific enzyme inhibitors is a therapeutic strategy.
Modulation of oxidative stress, scavenging of free radicals, inhibition of lipid peroxidation enzymes (e.g., LOXs), iron chelation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid Peroxidation Pathway (LPP).